Titre : Immunogénicité des vaccins

Immunogénicité des vaccins : Questions médicales fréquentes

Termes MeSH sélectionnés :

Reference Values
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Immunogénicité des vaccins : Questions médicales les plus fréquentes", "headline": "Immunogénicité des vaccins : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Immunogénicité des vaccins : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-05-20", "dateModified": "2025-05-15", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Immunogénicité des vaccins" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Phénomènes du système immunitaire", "url": "https://questionsmedicales.fr/mesh/D055633", "about": { "@type": "MedicalCondition", "name": "Phénomènes du système immunitaire", "code": { "@type": "MedicalCode", "code": "D055633", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "G12" } } }, "about": { "@type": "MedicalCondition", "name": "Immunogénicité des vaccins", "alternateName": "Immunogenicity, Vaccine", "code": { "@type": "MedicalCode", "code": "D000071497", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "None None", "url": "https://questionsmedicales.fr/author/None%20None", "affiliation": { "@type": "Organization", "name": "" } }, { "@type": "Person", "name": "Simin Wen", "url": "https://questionsmedicales.fr/author/Simin%20Wen", "affiliation": { "@type": "Organization", "name": "School of Public Health (Shenzhen), Sun Yat-sen University, Guangdong, China." } }, { "@type": "Person", "name": "Yuelong Shu", "url": "https://questionsmedicales.fr/author/Yuelong%20Shu", "affiliation": { "@type": "Organization", "name": "School of Public Health (Shenzhen), Sun Yat-sen University, Guangdong, China." } }, { "@type": "Person", "name": "Mohamed J Saadh", "url": "https://questionsmedicales.fr/author/Mohamed%20J%20Saadh", "affiliation": { "@type": "Organization", "name": "Department of Pharmacy, Faculty of Pharmacy, Middle East University, Amman, Jordan." } }, { "@type": "Person", "name": "Eduardo Lacson", "url": "https://questionsmedicales.fr/author/Eduardo%20Lacson", "affiliation": { "@type": "Organization", "name": "" } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "The correlates and reference values for the 6-minute walk distance in Taiwanese adults with schizophrenia.", "datePublished": "2022-09-24", "url": "https://questionsmedicales.fr/article/36151891", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1080/09638288.2022.2125592" } }, { "@type": "ScholarlyArticle", "name": "Reference values for 4D flow magnetic resonance imaging of the portal venous system.", "datePublished": "2023-04-04", "url": "https://questionsmedicales.fr/article/37016247", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s00261-023-03892-3" } }, { "@type": "ScholarlyArticle", "name": "Reference values of diaphragmatic dimensions in healthy children aged 0-8 years.", "datePublished": "2023-03-20", "url": "https://questionsmedicales.fr/article/36939879", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s00431-023-04920-6" } }, { "@type": "ScholarlyArticle", "name": "Evaluation of Standard and Proposed Reference Values for Entheseal Thickening by Using Musculoskeletal Ultrasound.", "datePublished": "2022-11-15", "url": "https://questionsmedicales.fr/article/36379580", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3899/jrheum.210148" } }, { "@type": "ScholarlyArticle", "name": "Sonographic reference values of cranial nerve size: A systematic review and meta-analysis.", "datePublished": "2022-07-15", "url": "https://questionsmedicales.fr/article/35765722", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1002/mus.27670" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Phénomènes du système immunitaire", "item": "https://questionsmedicales.fr/mesh/D055633" }, { "@type": "ListItem", "position": 3, "name": "Immunogénicité des vaccins", "item": "https://questionsmedicales.fr/mesh/D000071497" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Immunogénicité des vaccins - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Immunogénicité des vaccins", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-19", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Immunogénicité des vaccins", "description": "Comment évaluer l'immunogénicité d'un vaccin ?\nQuels tests sont utilisés pour mesurer l'immunité ?\nQuand effectuer un test d'immunogénicité ?\nQuels facteurs influencent l'immunogénicité ?\nPeut-on mesurer l'immunité cellulaire ?", "url": "https://questionsmedicales.fr/mesh/D000071497?mesh_terms=Reference+Values&page=3#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Immunogénicité des vaccins", "description": "Quels symptômes indiquent une bonne réponse immunitaire ?\nY a-t-il des effets secondaires liés à l'immunogénicité ?\nComment reconnaître une réaction allergique au vaccin ?\nLes symptômes varient-ils selon le vaccin ?\nQuels signes indiquent une réponse immunitaire faible ?", "url": "https://questionsmedicales.fr/mesh/D000071497?mesh_terms=Reference+Values&page=3#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Immunogénicité des vaccins", "description": "Comment maximiser l'immunogénicité d'un vaccin ?\nLes vaccins sont-ils sûrs pour tous ?\nComment informer sur les vaccins ?\nLes vaccins peuvent-ils être administrés pendant la grossesse ?\nQuelles sont les recommandations pour les enfants ?", "url": "https://questionsmedicales.fr/mesh/D000071497?mesh_terms=Reference+Values&page=3#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Immunogénicité des vaccins", "description": "Comment traiter une réaction indésirable au vaccin ?\nY a-t-il des traitements pour améliorer l'immunogénicité ?\nLes immunosuppresseurs affectent-ils l'immunogénicité ?\nComment gérer une infection après vaccination ?\nLes vaccins nécessitent-ils des rappels ?", "url": "https://questionsmedicales.fr/mesh/D000071497?mesh_terms=Reference+Values&page=3#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Immunogénicité des vaccins", "description": "Quelles sont les complications possibles des vaccins ?\nComment gérer une complication post-vaccinale ?\nLes complications sont-elles fréquentes ?\nLes vaccins peuvent-ils causer des maladies ?\nQuels sont les signes d'une complication grave ?", "url": "https://questionsmedicales.fr/mesh/D000071497?mesh_terms=Reference+Values&page=3#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Immunogénicité des vaccins", "description": "Quels facteurs augmentent le risque d'effets secondaires ?\nLes maladies chroniques affectent-elles l'immunogénicité ?\nLe statut immunitaire influence-t-il la vaccination ?\nLes antécédents de vaccination influencent-ils l'immunogénicité ?\nL'alimentation joue-t-elle un rôle dans l'immunogénicité ?", "url": "https://questionsmedicales.fr/mesh/D000071497?mesh_terms=Reference+Values&page=3#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment évaluer l'immunogénicité d'un vaccin ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Par des tests sérologiques mesurant les anticorps spécifiques post-vaccination." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour mesurer l'immunité ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Les tests ELISA et les tests de neutralisation sont couramment utilisés." } }, { "@type": "Question", "name": "Quand effectuer un test d'immunogénicité ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Idéalement 2 à 4 semaines après la vaccination pour évaluer la réponse." } }, { "@type": "Question", "name": "Quels facteurs influencent l'immunogénicité ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "L'âge, l'état de santé et le type de vaccin peuvent affecter l'immunogénicité." } }, { "@type": "Question", "name": "Peut-on mesurer l'immunité cellulaire ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Oui, par des tests comme l'IFN-gamma ELISPOT pour évaluer les lymphocytes T." } }, { "@type": "Question", "name": "Quels symptômes indiquent une bonne réponse immunitaire ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Une élévation des anticorps et des signes d'inflammation locale peuvent indiquer une réponse." } }, { "@type": "Question", "name": "Y a-t-il des effets secondaires liés à l'immunogénicité ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Des effets comme fièvre ou douleur au site d'injection peuvent survenir, mais sont normaux." } }, { "@type": "Question", "name": "Comment reconnaître une réaction allergique au vaccin ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Des symptômes comme éruption cutanée, démangeaisons ou difficulté respiratoire peuvent survenir." } }, { "@type": "Question", "name": "Les symptômes varient-ils selon le vaccin ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, chaque vaccin peut provoquer des symptômes différents selon sa composition." } }, { "@type": "Question", "name": "Quels signes indiquent une réponse immunitaire faible ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Un faible taux d'anticorps ou des infections récurrentes peuvent indiquer une réponse faible." } }, { "@type": "Question", "name": "Comment maximiser l'immunogénicité d'un vaccin ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "En respectant le calendrier vaccinal et en évitant les immunosuppresseurs avant vaccination." } }, { "@type": "Question", "name": "Les vaccins sont-ils sûrs pour tous ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "La plupart des vaccins sont sûrs, mais certaines personnes peuvent avoir des contre-indications." } }, { "@type": "Question", "name": "Comment informer sur les vaccins ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Fournir des informations claires et basées sur des preuves pour rassurer les patients." } }, { "@type": "Question", "name": "Les vaccins peuvent-ils être administrés pendant la grossesse ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Certains vaccins sont recommandés pendant la grossesse pour protéger la mère et l'enfant." } }, { "@type": "Question", "name": "Quelles sont les recommandations pour les enfants ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Les enfants doivent suivre le calendrier vaccinal pour une protection optimale." } }, { "@type": "Question", "name": "Comment traiter une réaction indésirable au vaccin ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Des antihistaminiques ou des anti-inflammatoires peuvent être administrés selon les symptômes." } }, { "@type": "Question", "name": "Y a-t-il des traitements pour améliorer l'immunogénicité ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Des adjuvants peuvent être ajoutés aux vaccins pour renforcer la réponse immunitaire." } }, { "@type": "Question", "name": "Les immunosuppresseurs affectent-ils l'immunogénicité ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Oui, ils peuvent réduire l'efficacité des vaccins en diminuant la réponse immunitaire." } }, { "@type": "Question", "name": "Comment gérer une infection après vaccination ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Un suivi médical est nécessaire, et des traitements antiviraux peuvent être envisagés." } }, { "@type": "Question", "name": "Les vaccins nécessitent-ils des rappels ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des rappels peuvent être nécessaires pour maintenir une immunité adéquate." } }, { "@type": "Question", "name": "Quelles sont les complications possibles des vaccins ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des complications rares incluent des réactions allergiques sévères ou des syndromes neurologiques." } }, { "@type": "Question", "name": "Comment gérer une complication post-vaccinale ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Un suivi médical est essentiel, et des traitements symptomatiques peuvent être nécessaires." } }, { "@type": "Question", "name": "Les complications sont-elles fréquentes ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Non, la plupart des complications sont rares par rapport aux bénéfices des vaccins." } }, { "@type": "Question", "name": "Les vaccins peuvent-ils causer des maladies ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Les vaccins inactivés ne causent pas de maladies, mais les vivants atténués peuvent provoquer des symptômes légers." } }, { "@type": "Question", "name": "Quels sont les signes d'une complication grave ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Des signes comme une forte fièvre, des convulsions ou des difficultés respiratoires nécessitent une attention immédiate." } }, { "@type": "Question", "name": "Quels facteurs augmentent le risque d'effets secondaires ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "L'âge avancé, les allergies et les antécédents médicaux peuvent augmenter le risque." } }, { "@type": "Question", "name": "Les maladies chroniques affectent-elles l'immunogénicité ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines maladies chroniques peuvent diminuer la réponse immunitaire aux vaccins." } }, { "@type": "Question", "name": "Le statut immunitaire influence-t-il la vaccination ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un statut immunitaire affaibli peut réduire l'efficacité des vaccins." } }, { "@type": "Question", "name": "Les antécédents de vaccination influencent-ils l'immunogénicité ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des vaccinations antérieures peuvent moduler la réponse immunitaire aux nouveaux vaccins." } }, { "@type": "Question", "name": "L'alimentation joue-t-elle un rôle dans l'immunogénicité ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Une alimentation équilibrée peut soutenir une réponse immunitaire optimale après vaccination." } } ] } ] }

Sources (10000 au total)

The correlates and reference values for the 6-minute walk distance in Taiwanese adults with schizophrenia.

The study aimed to identify the factors associated with the 6-min walk distance (6MWD) and to provide reference values for the 6MWD in individuals with schizophrenia (SCZ) in Taiwan.... A proportional stratified sampling method was utilized based on distribution of gender, age and body mass index (BMI) at the study hospital. The 6-minute walk test was conducted according to the Ameri... A total of 237 patients with SCZ completed the 6-minute walk test. The 6MWD was significantly associated with age, height, weight, and length of the onset of SCZ. Stepwise linear regression revealed t... Height and age were the main predictors for 6MWD among people with SCZ in Taiwan. The established reference values can be used to identify those at risk of poor cardiorespiratory fitness and as a targ...

Reference values for 4D flow magnetic resonance imaging of the portal venous system.

The purpose of this work was to establish normal reference values for 4D flow MRI-derived flow, velocity, and vessel diameters, and to define characteristic flow patterns in the portal venous system o... For this retrospective study, we screened all available 4D flow MRI exams of the upper abdomen in healthy adults acquired at our institution between 2012 and 2022 at either 1.5 T or 3.0 T MRI after ≥ ... We included 44 healthy subjects (26 female, 18-74 years) in the analysis. We report reference values for mean and peak flow, mean velocity, and vessel diameter in the healthy portal vein using 4D flow... We have reported normal hemodynamic values that are necessary baseline data for emerging clinical applications of 4D flow MRI in the portal venous system. Results are consistent with previously publis...

Evaluation of Standard and Proposed Reference Values for Entheseal Thickening by Using Musculoskeletal Ultrasound.

Ultrasound (US) is increasingly used to evaluate enthesitis. One of the US features of enthesitis is thickening. However, there is no consensus on how the entheseal thickening needs to be defined, and... Eighty HCs and 100 patients with axSpA had US scans of 2160 entheses. Sensitivity, specificity, odds ratio (OR), and accuracy were calculated according to accepted cut-off levels from the literature a... Thickening according to current cut-off levels was found in 20.4% (196/960) of healthy participants' entheses and 33% (396/1200) of entheses of patients with axSpA. Thickening according to proposed cu... Although using cut-offs appears to be an appealing method to evaluate entheseal thickness, the measurements may be affected by several confounding factors, leading to a low discriminative value, excep...

Sonographic reference values of cranial nerve size: A systematic review and meta-analysis.

Ultrasonography of the cranial nerves has recently gained attention for assessment of inflammatory, compressive, or degenerative neuropathies. However, sonographic reference values of cranial nerves h... By searching Medline (via PubMed), Scopus, Embase, Cochrane Central Register of Controlled Trials (CENTRAL), and Web of Science, we conducted a systematic review and meta-analysis of studies that repo... Fourteen studies with a total of 661 participants and 1437 ultrasound nerve measurements met the inclusion criteria. The anatomical sites for each nerve were combined to provide single-nerve mean meas... This meta-analysis provides reference values for the diameter and cross-sectional area of the facial, spinal accessory, and hypoglossal nerves at different sites, which can be used as guidance in clin...

Knee injury and osteoarthritis outcome score (KOOS) - National record-based reference values.

Knee Injury and Osteoarthritis Outcome Score (KOOS) and the short form KOOS-12 are commonly used in clinical practice and research but there are no national record-based reference values to aid interp... A national record-based representative sample of 9996 adult citizens were derived from the Danish Civil Registration System. The selection of citizens was based on seven predefined age groups with an ... A total of 2842 participants completed the KOOS, 1463 women (51.4%) and 1379 men (48.6%). The mean KOOS subscale scores were: pain 85.3 (95% confidence interval (CI): 84.6-85.9), symptoms 85.1 (95% CI... KOOS and KOOS-12 reference values can, in most situations, be used without stratification for age and sex. Sport/recreation reference values stratified for age and BMI may be of importance....

Blood routine reference value range should be adjusted according to regional and ethnic characteristics.

To further understand the influence of regional and ethnic factors on blood routine indicators.... The routine blood test (RBT) results of 617 healthy men aged 18-45 years old of the Li, Tibet, and Han nationalities living in the city of Sanya, Hainan Province (200 m), the city of Xining, Qinghai P... With an increase in altitude, the RBT index values and change trends of the different ethnic groups were different. When the altitude increased by 2,000 m, the RBC and Hb increased by 6.6 and 8.1%, re... Regional and ethnic factors have a significant impact on the RBT, and the current range of normal values of the RBT in China needs to be revised and adjusted....

An initial set of reference values for the Balance Tracking System (BTrackS) Limits of Stability protocol.

The Balance Tracking System (BTrackS) Limits of Stability (LOS) protocol is a relatively new means of evaluating unconstrained dynamic postural control ability. While the reliability of this protocol ... What are typical reference values for the BTrackS LOS protocol with respect to sex, height, and BMI?... A cross= -section of 800 healthy, young adults (aged 18-29 years; 368 men, 432 women) were administered the BTrackS LOS protocol. Sex, height and weight variables were also captured for the participan... Results of a stepwise linear regression showed that the outcome measure for BTrackS LOS testing (i.e. LOS Area) was larger in taller individuals and in men. Based on these findings, four percentile ra... The reference values provided by this study offer much needed guidance to clinicians and researchers for the determination of dynamic balance abnormalities based on BTrackS LOS testing....